BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23195289)

  • 1. Managing persistent ovarian follicles in premenopausal women fitted with the levonorgestrel-releasing intrauterine system.
    Morelli M; Di Cello A; Zullo F
    Int J Gynaecol Obstet; 2013 Feb; 120(2):187. PubMed ID: 23195289
    [No Abstract]   [Full Text] [Related]  

  • 2. Ovarian cysts: presence and persistence with use of a 13.5mg levonorgestrel-releasing intrauterine system.
    Nahum GG; Kaunitz AM; Rosen K; Schmelter T; Lynen R
    Contraception; 2015 May; 91(5):412-7. PubMed ID: 25661510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enlarged ovarian follicles in users of a levonorgestrel-releasing intrauterine system and contraceptive implant.
    Bahamondes L; Hidalgo M; Petta CA; Diaz J; Espejo-Arce X; Monteiro-Dantas C
    J Reprod Med; 2003 Aug; 48(8):637-40. PubMed ID: 12971147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levonorgestrel-releasing intrauterine system causes a lichenoid drug eruption.
    Jones JA; Shuler MJ; Zlotoff BJ
    Cutis; 2015 Jul; 96(1):E13-5. PubMed ID: 26244359
    [No Abstract]   [Full Text] [Related]  

  • 5. Levonorgestrel intrauterine device (IUD) exacerbation of PMS symptoms.
    Appiani FJ; Carroll BT
    Ann Clin Psychiatry; 2014 May; 26(2):146-7. PubMed ID: 24812652
    [No Abstract]   [Full Text] [Related]  

  • 6. Marked increase of breast density due to a levonorgestrel-releasing intrauterine device.
    Gossner J
    JBR-BTR; 2013; 96(6):396. PubMed ID: 24617194
    [No Abstract]   [Full Text] [Related]  

  • 7. Levonorgestrel-releasing intrauterine device and uterine perforations.
    Prescrire Int; 2007 Dec; 16(92):248-9. PubMed ID: 18092420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levonorgestrel-releasing intra-uterine systems (LNG-IUS) and breast cancer.
    Neven P; Amant F; Poppe W; Van den Broecke R
    Fertil Steril; 2009 Apr; 91(4):e5; author reply e6. PubMed ID: 19249759
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of the levonorgestrel releasing-intrauterine system in nulliparous women--a non-interventional study in Sweden.
    Marions L; Lövkvist L; Taube A; Johansson M; Dalvik H; Øverlie I
    Eur J Contracept Reprod Health Care; 2011 Apr; 16(2):126-34. PubMed ID: 21417562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterotopic cesarean scar pregnancy associated with a levonorgestrel-releasing intrauterine device.
    Dueñas-Garcia OF; Young C
    Int J Gynaecol Obstet; 2011 Aug; 114(2):153-4. PubMed ID: 21679948
    [No Abstract]   [Full Text] [Related]  

  • 11. The levonorgestrel-releasing intrauterine system in modern gynaecology.
    McGavigan CJ; Owen P
    Br J Hosp Med (Lond); 2005 Oct; 66(10):574-7. PubMed ID: 16255257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The benefits and risks of using a levonorgestrel-releasing intrauterine system for contraception.
    Mansour D
    Contraception; 2012 Mar; 85(3):224-34. PubMed ID: 22067761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe seborrhoeic dermatitis: side-effect of the Mirena intra-uterine system.
    Karri K; Mowbray D; Adams S; Rendal JR
    Eur J Contracept Reprod Health Care; 2006 Mar; 11(1):53-4. PubMed ID: 16546818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension and use of an intrauterine levonorgestrel-releasing device.
    Vos AG; van de Ree MA
    Neth J Med; 2012 Nov; 70(9):431. PubMed ID: 23123543
    [No Abstract]   [Full Text] [Related]  

  • 15. Endometrial adenocarcinoma in association with a levonorgestrel-releasing intrauterine system (Mirena).
    Ndumbe FM; Husemeyer RP
    J Fam Plann Reprod Health Care; 2006 Apr; 32(2):113-4. PubMed ID: 16824305
    [No Abstract]   [Full Text] [Related]  

  • 16. Gynaecological aspects of the levonorgestrel-releasing intrauterine system.
    Sturridge F; Guillebaud J
    Br J Obstet Gynaecol; 1997 Mar; 104(3):285-9. PubMed ID: 9091003
    [No Abstract]   [Full Text] [Related]  

  • 17. Kyleena--another hormonal IUD.
    Med Lett Drugs Ther; 2017 Feb; 59(1515):38-39. PubMed ID: 28222064
    [No Abstract]   [Full Text] [Related]  

  • 18. ▼Jaydess IUS.
    Drug Ther Bull; 2015 Jan; 53(1):9-12. PubMed ID: 25592689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Releasing Intrauterine System of Levonorgestrel and risk for breast cancer. ].
    Scapinelli A; Oliveira VM; Takagi MM; Aldrighi JM
    Rev Assoc Med Bras (1992); 2010; 56(6):636-7. PubMed ID: 21271125
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mirena--the first intrauterine contraceptive therapeutic system].
    Rachev E
    Akush Ginekol (Sofiia); 2001; 40 Suppl 6():3-6. PubMed ID: 11803883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.